METIS TECHBIO-P (7666.HK) — Stock Score Summary

METIS TECHBIO-P (7666.HK) has a MoatMap StockRank of 8/100 based on Quality (31/100), Value (31/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL. METIS TECHBIO-P is a highly speculative, pre-revenue biotech entity. It fails our Terry Smith lens, which strictly avoids early-stage, non-cash-generative businesses, and does not possess the validated, high-utilization manufacturing scale of a leading CDMO.

Metis Pharmaceuticals (Metis Techbio) is a biotechnology company utilizing artificial intelligence and high-throughput formulation platforms to optimize drug delivery and develop novel therapeutics. The company specializes in lipid nanoparticle (LNP) delivery systems for mRNA and other nucleic acid therapies. Its competitive advantage lies in its proprietary AI-driven formulation design platform, which significantly accelerates the development of complex drug delivery systems.

Key Financial Metrics

Price$1.56
Market Cap$2.2B
Price/Book1.10
Return on Invested Capital-32.2%
Gross Margin98.2%
Operating Margin-356.6%
Free Cash Flow$-215K

METIS TECHBIO-P operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is METIS TECHBIO-P’s (7666.HK) StockRank?
MoatMap’s StockRank for METIS TECHBIO-P (7666.HK) is 8/100, with a Strong Sell signal. It is a composite of Quality (31), Value (31), and Momentum (25) factor ranks across MoatMap’s 19,000+ stock universe.
Does METIS TECHBIO-P have an economic moat?
METIS TECHBIO-P (7666.HK) has a Quality factor score of 31/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is METIS TECHBIO-P a buy, hold, or sell?
MoatMap’s current signal for METIS TECHBIO-P (7666.HK) is Strong Sell, based on a StockRank of 8/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is METIS TECHBIO-P in?
METIS TECHBIO-P (7666.HK) operates in the Healthcare sector, specifically the Biotechnology industry (China).
Browse all ranked stocks7666.HK deep dive reportAI ChampionsHow we score stocksSense-check another stock